Andrew E Cornish
Overview
Explore the profile of Andrew E Cornish including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
1241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Cornish A, Do M, Brunner J, Hsu T, Xu Z, et al.
bioRxiv
. 2024 Apr;
PMID: 38617314
How genetic lesions drive cell transformation and whether they can be circumvented without compromising function of non-transformed cells are enduring questions in oncology. Here we show that in mature T...
2.
Li M, Zhang J, Xu Z, Zhang X, Li P, Cornish A
Annu Rev Immunol
. 2024 Feb;
42(1):647-677.
PMID: 38424658
Lymphocytes spanning the entire innate-adaptive spectrum can stably reside in tissues and constitute an integral component of the local defense network against immunological challenges. In tight interactions with the epithelium...
3.
Nazaret A, Fan J, Lavallee V, Burdziak C, Cornish A, Kiseliovas V, et al.
bioRxiv
. 2023 Nov;
PMID: 38014231
Biological insights often depend on comparing conditions such as disease and health, yet we lack effective computational tools for integrating single-cell genomics data across conditions or characterizing transitions from normal...
4.
Nixon B, Chou C, Krishna C, Dadi S, Michel A, Cornish A, et al.
Sci Immunol
. 2022 Apr;
7(70):eabi8642.
PMID: 35394814
Innate lymphocytes are integral components of the cellular immune system that can coordinate host defense against a multitude of challenges and trigger immunopathology when dysregulated. Natural killer (NK) cells and...
5.
Goswami S, Walle T, Cornish A, Basu S, Anandhan S, Fernandez I, et al.
Nat Med
. 2019 Dec;
26(1):39-46.
PMID: 31873309
Immune checkpoint therapy with anti-CTLA-4 and anti-PD-1/PD-L1 has revolutionized the treatment of many solid tumors. However, the clinical efficacy of immune checkpoint therapy is limited to a subset of patients...
6.
Azizi E, Carr A, Plitas G, Cornish A, Konopacki C, Prabhakaran S, et al.
Cell
. 2018 Jul;
174(5):1293-1308.e36.
PMID: 29961579
Knowledge of immune cell phenotypes in the tumor microenvironment is essential for understanding mechanisms of cancer progression and immunotherapy response. We profiled 45,000 immune cells from eight breast carcinomas, as...